Why Are These 5 NZX Stocks Drawing Investors’ Attention Today- FPH, SEK, PEB, FWL, AFT

Several companies made significant announcements on the NZX today and they are getting investors’ attention for the same. Let’s have a look at what impact these announcements had on the stocks of these companies today.

Fisher and Paykel Healthcare Corporation  (NZX:FPH, ASX:FPH)

Auckland-based Fisher & Paykel Healthcare announced on Tuesday that it would report its full-year results on 27 May 2021 for the year ended 31 March 2021. This will be a much-awaited event as FPH was one of the fastest growing companies in 2020. It performed beyond expectations due to the healthcare equipment that supports respiratory process.
Also Read: How will NZX-50 listed AIA, FPH, MEL perform in 2021?

The result will be issued before 9 am NZST and will also be discussed through a conference call. The conference call is scheduled to begin at 10 am NZST and will also be broadcast on the Internet. On 4 May 2021, the stock was trading down by 0.17% at NZ$35.290 at the time of writing.

Image Source: Copyright © 2021 Kalkine Media Pty Ltd

Seeka Limited (NZX:SEK)

SEK, which is an integrated horticulture company that indulges in complete farm to market practices, announced on Tuesday that its merger with Opotiki Packing and Cool Storage Limited (OPAC) was complete. 

The NZ$59M transaction and all conditions related to the transaction were taken care of with full support of all stakeholders, including OPAC growers and Westpac bank. SEK disclosed that it would issue 7,042,574 new shares to OPAC shareholders and take on NZ$25.09M of debt of OPAC.

Also Read: A Sneak Peek at 6 NZX Gainer and Losers Of The Day--ARB, SEK, AMP, ATM, MEE, CRP?

The Company now moves to the next phase of integration of both the companies, and the immediate focus the management said would be on to conduct a safe and successful harvest.

At the time of writing On 4 May 2021, the stock was trading down by 0.18% at NZ$5.490.

Pacific Edge Limited (NZX: PEB)

Cancer diagnostics company PEB announced on Tuesday that it had appointed Mark Green as an Independent Director, with effect from 10 May 2021. The new Director has 25 years of experience as a corporate finance professional. He was earlier the Executive Director for Investment Banking at Goldman Sachs. He has been involved in many IPOs and other NZ transactions.
Also Read: Infratil Pens a Deal To Acquire A Stake In Pacific Radiology

On his appointment as an Independent Director of PEB, Mark said that PEB was an exciting company that was seeking to become big in cancer diagnostics. He said he was very proud to be involved with such a company.

At the time of writing on 4 May 2021, the stock was trading down by 0.87% at NZ$1.140.

Foley Wines Limited (NZX: FWL)

Foley Wines announced that it had completed its harvest for the 2021 vintage.
The harvest was down as compared to the previous year. It totaled 5,582 tonnes across the Marlborough, Martinborough, and Mt Difficulty wineries, which marked an overall decrease by 28%. The Company is working on making the products premium so that they can offset the loss due to higher vintage cost.

Also Read: Take a Peek at NZ Wine Industry and Related Stocks- DGL, FWL, MWE

At the time of writing on 4 May 2021, the stock was trading down by 0.56% at NZ$1.790.

AFT Pharmaceuticals (NZX: AFT, ASX: AFP)

AFT announced on Tuesday that it would be reporting its full-year earnings on Monday, May 24, 2021. The time of the release will be around 9 am.

This will be followed by a presentation and a teleconference. The investors will be able to access the presentation on the Company website.

At the time of writing on 4 May 2021, the stock was trading up by 0.64% at NZ$4.700.


Disclaimer
The website https://kalkinemedia.com/nz is a service of Kalkine Media New Zealand Limited (Kalkine Media), Company Number: 8107196. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.
   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK